Three Biotechs That Takeover: Top 2026 M&A Targets
As large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesAs large pharma hunts for GLP-1 and cardiovascular assets, three biotechs stand out as hot takeover targets. This rep...
A growing wave of americans retiring north border is eyeing Alberta for lower taxes and affordable housing, but long-...
New IRS data released Friday tracks audit activity at the start of Trump’s second term, showing selective enforcement...
AMD has ridden a steep year-to-date surge powered by AI and cloud demand. Analysts warn the rally faces hurdles, but ...
Inflation stays elevated as June 2026 data roll in, shaping budgets and investment plans. This piece explains what co...
NVIDIA’s market value dips below the $5 trillion threshold as traders reassess AI demand and supply dynamics. Analyst...
The ITA ETF just ripped higher again, underscoring a multi-year upcycle in America’s rearmament push. Here’s what inv...
A small group of retirees collects about $62,172 yearly from Social Security by following a strict earnings and claim...
Big AI-driven demand is reshaping data-center stocks. Terawulf and IREN rallied as investors priced in new compute ca...
A fast-growing tech name in the AI space has dazzled investors, but a recent funding move underscored a crucial risk....
Copper prices sit near multi-month highs in March 2026, and investors are eyeing a Chile-focused ETF as a clean coppe...
Suze Orman warns against rushing to sell a primary residence in today’s volatile market, advocating a HELOC bridge to...